Teclistamab in Relapsed or Refractory Multiple Myeloma.
N Engl J Med
; 387(6): 495-505, 2022 08 11.
Article
in En
| MEDLINE
| ID: mdl-35661166
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
CD3 Complex
/
Antibodies, Bispecific
/
B-Cell Maturation Antigen
/
Antineoplastic Agents, Immunological
/
Multiple Myeloma
Limits:
Humans
Language:
En
Journal:
N Engl J Med
Year:
2022
Document type:
Article